CRONOS GROUP INC. Research and Development Expense
CRONOS GROUP INC. (CRON) reported Research and Development Expense of $1.22 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:ResearchAndDevelopmentExpense · last filed 2026-08-06
- CRONOS GROUP INC. research and development expense for the quarter ending 2026-06-30 was $1.22M, a 30.79% increase year-over-year.
- CRONOS GROUP INC. research and development expense for the quarter ending 2026-03-31 was $1.41M, a 78.18% increase year-over-year.
- CRONOS GROUP INC. research and development expense for the quarter ending 2025-12-31 was $1.38M, a 34.44% increase year-over-year.
- CRONOS GROUP INC. research and development expense for the quarter ending 2025-09-30 was $1.34M, a 8.29% increase year-over-year.
- CRONOS GROUP INC. research and development expense for fiscal 2025 was $4.45M, a 5.20% increase from fiscal 2024.
- CRONOS GROUP INC. research and development expense for fiscal 2024 was $4.23M, a 27.62% decline from fiscal 2023.
- CRONOS GROUP INC. research and development expense for fiscal 2023 was $5.84M, a 55.50% decline from fiscal 2022.
- CRONOS GROUP INC. research and development expense for fiscal 2022 was $13.13M, a 39.88% decline from fiscal 2021.
| Period end | Research and Development Expense 3 month | Research and Development Expense 3 month as first filed | Research and Development Expense 6 month | Research and Development Expense 6 month as first filed | Research and Development Expense 9 month | Research and Development Expense 9 month as first filed | Research and Development Expense 12 month | Research and Development Expense 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $1.22M 10-Q · filed 2026-08-06 | $2.63M 10-Q · filed 2026-08-06 | $4.01M derived: sum of 3 quarters · filed 2026-08-06 | $5.36M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2026-03-31 | $1.41M 10-Q · filed 2026-05-11 | $2.79M derived: sum of 2 quarters · filed 2026-05-11 | $4.14M derived: sum of 3 quarters · filed 2026-05-11 | $5.07M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-12-31 | $1.38M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.73M derived: sum of 2 quarters · filed 2026-02-26 | $3.66M derived: sum of 3 quarters · filed 2026-08-06 | $4.45M 10-K · filed 2026-02-26 | ||||
| 2025-09-30 | $1.34M 10-Q · filed 2025-11-06 | $2.27M derived: sum of 2 quarters · filed 2026-08-06 | $3.07M 10-Q · filed 2025-11-06 | $4.09M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-06-30 | $929.00K 10-Q · filed 2026-08-06 | $1.72M 10-Q · filed 2026-08-06 | $2.75M derived: sum of 3 quarters · filed 2026-08-06 | $3.99M derived: sum of 4 quarters · filed 2026-08-06 | ||||
| 2025-03-31 | $793.00K 10-Q · filed 2026-05-11 | $1.82M derived: sum of 2 quarters · filed 2026-05-11 | $3.06M derived: sum of 3 quarters · filed 2026-05-11 | $4.03M derived: sum of 4 quarters · filed 2026-05-11 | ||||
| 2024-12-31 | $1.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.27M derived: sum of 2 quarters · filed 2026-02-26 | $3.23M derived: sum of 3 quarters · filed 2026-02-26 | $4.23M 10-K · filed 2026-02-26 | ||||
| 2024-09-30 | $1.24M 10-Q · filed 2025-11-06 | $2.20M derived: sum of 2 quarters · filed 2025-11-06 | $3.20M 10-Q · filed 2025-11-06 | $4.65M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-06-30 | $962.00K 10-Q · filed 2025-08-07 | $1.96M 10-Q · filed 2025-08-07 | $3.41M derived: sum of 3 quarters · filed 2026-02-26 | $4.66M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2024-03-31 | $997.00K 10-Q · filed 2025-05-08 | $2.45M derived: sum of 2 quarters · filed 2026-02-26 | $3.69M derived: sum of 3 quarters · filed 2026-02-26 | $4.80M derived: sum of 4 quarters · filed 2026-02-26 | ||||
| 2023-12-31 | $1.45M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $2.70M derived: sum of 2 quarters · filed 2026-02-26 | $3.80M derived: sum of 3 quarters · filed 2026-02-26 | $5.84M 10-K · filed 2026-02-26 | ||||
| 2023-09-30 | $1.25M 10-Q · filed 2024-11-12 | $2.35M derived: sum of 2 quarters · filed 2024-11-12 | $4.39M 10-Q · filed 2024-11-12 | $6.87M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-06-30 | $1.11M 10-Q · filed 2024-08-08 | $3.15M 10-Q · filed 2024-08-08 | $5.62M derived: sum of 3 quarters · filed 2025-02-27 | $8.16M derived: sum of 4 quarters · filed 2025-02-27 | ||||
| 2023-03-31 | $2.04M 10-Q · filed 2024-05-09 | $2.04M 10-Q · filed 2023-05-09 | $4.51M derived: sum of 2 quarters · filed 2025-02-27 | $7.05M derived: sum of 3 quarters · filed 2025-02-27 | $11.25M derived: sum of 4 quarters · filed 2025-02-27 | |||
| 2022-12-31 | $2.48M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $5.02M derived: sum of 2 quarters · filed 2025-02-27 | $9.21M derived: sum of 3 quarters · filed 2025-02-27 | $13.13M 10-K · filed 2025-02-27 | $13.38M 10-K · filed 2023-02-28 | |||
| 2022-09-30 | $2.54M 10-Q · filed 2023-11-08 | $2.57M 10-Q · filed 2022-11-07 | $6.74M derived: sum of 2 quarters · filed 2023-11-08 | $10.66M 10-Q · filed 2023-11-08 | $10.91M 10-Q · filed 2022-11-07 | $15.84M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-06-30 | $4.19M 10-Q · filed 2023-08-08 | $4.30M 10-Q · filed 2022-08-09 | $8.12M 10-Q · filed 2023-08-08 | $8.34M 10-Q · filed 2022-08-09 | $13.30M derived: sum of 3 quarters · filed 2024-02-29 | $19.77M derived: sum of 4 quarters · filed 2024-02-29 | ||
| 2022-03-31 | $4.04M 10-Q · filed 2023-05-09 | $9.11M derived: sum of 2 quarters · filed 2024-02-29 | $15.58M derived: sum of 3 quarters · filed 2024-02-29 | $20.78M derived: sum of 4 quarters · filed 2024-02-29 | ||||
| 2021-12-31 | $5.07M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $11.54M derived: sum of 2 quarters · filed 2024-02-29 | $16.74M derived: sum of 3 quarters · filed 2024-02-29 | $21.84M 10-K · filed 2024-02-29 | $23.33M 10-K · filed 2022-03-01 | |||
| 2021-09-30 | $6.47M 10-Q · filed 2022-11-07 | $11.67M derived: sum of 2 quarters · filed 2022-11-07 | $16.77M 10-Q · filed 2022-11-07 | $24.18M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-06-30 | $5.20M 10-Q · filed 2022-08-09 | $10.30M 10-Q · filed 2022-08-09 | $17.71M derived: sum of 3 quarters · filed 2023-02-28 | $22.45M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2021-03-31 | $5.10M 10-Q · filed 2022-05-10 | $12.51M derived: sum of 2 quarters · filed 2023-02-28 | $17.25M derived: sum of 3 quarters · filed 2023-02-28 | $20.88M derived: sum of 4 quarters · filed 2023-02-28 | ||||
| 2020-12-31 | $7.41M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | $12.14M derived: sum of 2 quarters · filed 2023-02-28 | $15.78M derived: sum of 3 quarters · filed 2023-02-28 | $20.37M 10-K · filed 2023-02-28 | ||||
| 2020-09-30 | $4.73M 10-Q · filed 2022-02-18 | $8.37M derived: sum of 2 quarters · filed 2022-02-18 | $12.96M 10-Q · filed 2022-02-18 | $19.03M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-06-30 | $3.63M 10-Q/A · filed 2022-02-18 | $8.22M 10-Q/A · filed 2022-02-18 | $14.30M derived: sum of 3 quarters · filed 2022-03-01 | $16.91M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2020-03-31 | $4.59M 10-Q · filed 2021-05-07 | $10.67M derived: sum of 2 quarters · filed 2022-03-01 | $13.27M derived: sum of 3 quarters · filed 2022-03-01 | $15.57M derived: sum of 4 quarters · filed 2022-03-01 | ||||
| 2019-12-31 | $6.08M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01 | $8.68M derived: sum of 2 quarters · filed 2022-03-01 | $10.98M derived: sum of 3 quarters · filed 2022-03-01 | $12.15M 10-K · filed 2022-03-01 | ||||
| 2019-09-30 | $2.60M 10-Q · filed 2020-11-05 | $4.91M derived: sum of 2 quarters · filed 2020-11-05 | $6.08M 10-Q · filed 2020-11-05 | |||||
| 2019-06-30 | $2.30M 10-Q · filed 2020-08-06 | $3.47M 10-Q · filed 2020-08-06 | ||||||
| 2019-03-31 | $1.17M 10-Q · filed 2020-05-08 | |||||||
| 2018-12-31 | $1.81M 10-K · filed 2021-02-26 | |||||||
| 2017-12-31 | $0.00 10-K/A · filed 2020-03-30 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tilray Brands, Inc. (TLRY) | United States | $0.554B | -5.97 |
| Canopy Growth Corp (CGC) | $0.395B | ||
| USANA HEALTH SCIENCES INC (USNA) | United States | $0.264B | -17.90 |
| Niagen Bioscience, Inc. (NAGE) | United States | $0.238B | 15.72 |
| FITLIFE BRANDS, INC. (FTLF) | United States | $0.087B | 16.59 |
| MANNATECH INC (MTEX) | United States | $0.014B | |
| NATURAL ALTERNATIVES INTERNATIONAL INC (NAII) | United States | $0.011B | -1.16 |
| Synergy CHC Corp. (SNYR) | United States | $0.001B | |
| Functional Brands Inc. (MEHA) | United States | $0.001B | |
| Definium Therapeutics, Inc. (DFTX) | United States | $4.931B | -17.87 |